CLINICAL_TRIALS
trial_result
· 2013-01-17
Clinical Trial Update: A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) [Phase 3]
Summary
Phase 3 trial evaluating ranibizumab injections for diabetic macular edema with center involvement has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Diabetes Mellitus, Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2013-01-17